STAT3 and neoplasm: Collectively, these data suggest that the expansion of stem-like cancer cells in tumor xenografts from ESE3KD-PrECs was associated with elevation of IL-6 and consequent activation of JAK/STAT3 and that it could be efficiently targeted by JAK/STAT3 inhibitors.